08580518 · Active · incorporated 13 years, 2 months ago · Abingdon
Biotech AI Biotech & Life Sciences Drug Discovery Series B+
A privately owned biotech company focused on developing therapeutics for neurodegenerative diseases, based on their novel molecule T14.
Neurobio is a private limited company registered at Companies House under number 08580518, incorporated on 21 June 2013, with a registered office in Abingdon, Oxfordshire. Its current status on the register is active. Its filed nature of business is other research and experimental development on natural sciences and engineering (SIC 72190). Sonde has indexed 152 filings for this company, including 13 funding rounds. Its most recent round closed in June 2026, raising £470k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 13 | Jun 2026 | £470k | £32.45 |
| Round 12 | Dec 2025 | £234k | £69.40 |
| Round 11 | Dec 2024 | £718k | £87.64 |
| Round 10 | Mar 2024 | £5.7m | £87.64 |
| Round 9 | Jun 2022 | £378k | £103.64 |
| Round 8 | Nov 2020 | £569k | £25.75 |
Showing the 6 most recent of 13 rounds.
Showing the 12 most recent of 152 filings.
See the complete cap table with every shareholder, founder tags, dilution across 91 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.